Dec 22nd, 2020
Jacobio Pharmaceuticals CEO on Hong Kong IPO, Biotech
Wang Yinxiang, chairman and chief executive officer at Jacobio Pharmaceuticals Group Co. Ltd, discusses the company’s IPO on Monday, what they’re planning to do with the funds and his outlook for biotech in China. He speaks exclusively on “Bloomberg Daybreak: Asia.” (Source: Bloomberg)











